The global Home
Infusion Therapy market size was estimated at USD 43.4 billion in 2021 and is expected to surpass around USD 65.2 billion by 2030 and poised to grow at a compound annual
growth rate (CAGR) of 4.63% during the forecast period 2022 to
2030.
Download
Free Sample@ https://www.novaoneadvisor.com/report/sample/6960
Key Takeaways:
Home infusion therapy refers to the process in which patients receive
treatment at home through the administration of drugs or biologicals through
catheters and needles. Receiving treatment at home as opposed to hospitals or
healthcare facilities is a cost-effective and more convenient option for
patients, further driving the need for home infusion therapy.
Home infusion
therapy involves the intravenous or subcutaneous administration of drugs or
biologicals to an individual at home. Favorable government policies and
regulations are expected to propel market growth. In February 2018, the
Bipartisan Budget Act of 2018 was signed into a law that states that all
temporary payments of home infusion therapy in the U.S. will be covered by the
government in accordance with this regulation.
In addition, the
rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs),
cancer, diabetes, and other life-threatening conditions, is expected to have a
high impact on the market growth. According to a WHO report, the
above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of
the disease burden in the U.S. in 2019. This creates the need to infuse
nutritional products that contain glutamine, phospholipids, glucose, and amino
acids while administering medication to patients, which, in turn, is expected
to boost the market growth in this region.
The ongoing COVID-19
pandemic is expected to create lucrative opportunities for the market. Due to
the restrictions caused by COVID-19, patients are waiting to seek treatment
until they feel safe. Moreover, patients who seek infusion therapy already have
diseases, which eventually weaken their immune systems. In such cases, going
outside even to receive treatment becomes a potential threat. Reduced operating
hours have led to difficulty in scheduling appointments as well, even if
patients choose to continue treatment. Hence, home infusion therapy is expected
to play a key role in supporting patients.
Report Scope of the Home Infusion Therapy
Market
|
Report Coverage |
Details |
|
Market Size in
2022 |
USD 45.41 Billion |
|
Market Size by
2030 |
USD 65.2 Billion |
|
Growth Rate from
2022 to 2030 |
CAGR of 4.63% |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Product,
Application, Route of Administration, End User, Geography |
|
Companies
Mentioned |
CVS/Coram, Option
Care Health, BriovaRx/Diplomat (UnitedHealth Optum, PharMerica, Fresenius
Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical
Electronics, Smith’s Medical, Terumo Corporation, JMS Co. Ltd., Others |
Product Insights
The infusion pumps
segment accounted for the largest revenue share of over 50.4% in 2021 as these pumps are widely preferred
for the delivery of nutrients and medications. On the basis of product, the
market for home infusion therapy is segmented into infusion pumps, ambulatory
infusion pumps, intravenous sets, IV cannulas, and needleless connectors. The
availability of a variety of products such as enteral, syringe, multichannel,
and peristaltic pumps further contributes to the segment growth. The rising
demand for syringes and ambulatory pumps owing to the increasing preference for
home healthcare is also anticipated to contribute to the segment growth.
Nowadays, smart
pumps are widely used as these pumps contain advanced features such as barcode
technology, which helps in the verification of a patient’s identity and
prevents drug administration errors. Needleless connectors are anticipated to
register the highest CAGR over the forecast period. These connectors offer
improved safety, enable smooth surgeries, and help adhere to good clinical
practice (GCP), which contributes to the growth of the segment.
Application Insights
The anti-infective
segment dominated the market for home infusion therapy in 2021 with a revenue
share of over 25.5%.
On the basis of application, the market has been segmented into anti-infective,
endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral
nutrition, and specialty pharmaceuticals. This is attributed to the
considerable number of procedures performed for the administration of
antifungal and antibiotic drugs. It also helps reduce exposure to patients with
other hospital-acquired infections (HAIs).
Chemotherapy is
estimated to be the fastest-growing segment over the forecast period. With the
growing incidences of cancer, the demand for pressure pumps is expected to
increase in the coming years. Pumps used for chemotherapy at home are compact,
continuous pressure pumps that do not require a battery and can hence be used
for a longer period of time. With the help of these pumps, chemotherapy drugs
can be administered at the appropriate infusion speed and in the right amounts.
Regional Insights
North America
dominated the market in 2021 with a revenue share of over 56% and this trend is expected to continue
throughout the forecast period. This can be attributed to the increasing
R&D in the region and the rising adoption of new technology in infusion
pumps. The increasing need for long-term therapy for patients with certain
conditions is driving the regional market. Development of alternate healthcare
settings and home infusion services and shifting preference from acute care to
home care settings due to the low cost and enhanced patient mobility would
boost the growth of this market in the coming years.
The Asia Pacific
market is expected to register the fastest CAGR of 9.7% over the forecast period. This is
attributed to rising patient awareness regarding the benefits of home infusion
therapy over in-hospital procedures and the growing prevalence of diabetes in
the region. The growing geriatric population and the rise in chronic diseases in
the region are expected to further fuel the market growth. According to the
Times of India, around 75 million people over the age of 60 years suffer from
some chronic disease in India, which might increase the adoption of home care
services in the country.
Some of
the prominent players in the Home Infusion Therapy Market include:
Segments
Covered in the Report
This report forecasts revenue growth at global, regional, and country
levels and provides an analysis of the latest industry trends in each of the
sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has
segmented the global Home Infusion Therapy market
By Product
By Application
By Route of Administration
By End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits for Stakeholders
Quick Buy This
Premium Report from Here@ https://www.novaoneadvisor.com/report/checkout/6960
You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333
About Us
Nova One Advisor is a worldwide market research and
consulting organization. We give unmatched nature of offering to our customers
present all around the globe across industry verticals. Nova One Advisor has
expertise in giving deep-dive market insight along with market intelligence to
our customers spread crosswise over various undertakings.
We are obliged to serve our different client base present
over the enterprises of medicinal services, healthcare, innovation, next-gen
technologies, semi-conductors, chemicals, automotive, and aerospace &
defense, among different ventures present globally.